Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Antila

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Chemical Physics|October 2, 2017
Repulsion between oppositely charged rod-shaped macromolecules: Role of overcharging and ionic confinementHanne S Antila, Paul R Van Tassel, Maria Sammalkorpi
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendanS Antila, T Honkanen, L Lehtonen, et al.
Physical Review. E|March 18, 2016
Interaction modes between asymmetrically and oppositely charged rodsHanne S Antila, Paul R Van Tassel, Maria Sammalkorpi
The Journal of Physical Chemistry. B|September 10, 2015
Ewald Electrostatics for Mixtures of Point and Continuous Line ChargesHanne S Antila, Paul R Van Tassel, Maria Sammalkorpi
International Journal of Pharmaceutics|June 28, 2002
Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsulesH Kortejärvi, J Mikkola, M Bäckman, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 25, 2002
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failureM Kivikko, S Antila, J Eha, et al.
European Journal of Clinical Pharmacology|April 11, 2001
Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techiqueH Heikkinen, M Saraheimo, S Antila, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 24, 1999
Site dependent bioavailability and metabolism of levosimendan in dogsS Antila, H Huuskonen, T Nevalainen, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteersJ Lilleberg, S Antila, M Karlsson, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 7, 1999
Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervalsS Sundberg, S Antila, H Scheinin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Chemical Physics|October 2, 2017
Repulsion between oppositely charged rod-shaped macromolecules: Role of overcharging and ionic confinementHanne S Antila, Paul R Van Tassel, Maria Sammalkorpi
International Journal of Clinical Pharmacology and Therapeutics|September 3, 1998
The CYP3A4 inhibitor intraconazole does not affect the pharmacokinetics of a new calcium-sensitizing drug levosimendanS Antila, T Honkanen, L Lehtonen, et al.
Physical Review. E|March 18, 2016
Interaction modes between asymmetrically and oppositely charged rodsHanne S Antila, Paul R Van Tassel, Maria Sammalkorpi
The Journal of Physical Chemistry. B|September 10, 2015
Ewald Electrostatics for Mixtures of Point and Continuous Line ChargesHanne S Antila, Paul R Van Tassel, Maria Sammalkorpi
International Journal of Pharmaceutics|June 28, 2002
Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsulesH Kortejärvi, J Mikkola, M Bäckman, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 25, 2002
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failureM Kivikko, S Antila, J Eha, et al.
European Journal of Clinical Pharmacology|April 11, 2001
Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techiqueH Heikkinen, M Saraheimo, S Antila, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 24, 1999
Site dependent bioavailability and metabolism of levosimendan in dogsS Antila, H Huuskonen, T Nevalainen, et al.
Clinical Pharmacology and Therapeutics|November 1, 1994
Pharmacokinetics and pharmacodynamics of simendan, a novel calcium sensitizer, in healthy volunteersJ Lilleberg, S Antila, M Karlsson, et al.
International Journal of Clinical Pharmacology and Therapeutics|January 7, 1999
Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervalsS Sundberg, S Antila, H Scheinin, et al.
Pageof 4